These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1964179)

  • 41. Regulation of nerve growth factor receptor mRNA content by dexamethasone: in vitro and in vivo studies.
    Yakovlev AG; De Bernardi MA; Fabrazzo M; Brooker G; Costa E; Mocchetti I
    Neurosci Lett; 1990 Aug; 116(1-2):216-20. PubMed ID: 2175403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for endocytosis-dependent proteolysis in the generation of soluble truncated nerve growth factor receptors by A875 human melanoma cells.
    Zupan AA; Johnson EM
    J Biol Chem; 1991 Aug; 266(23):15384-90. PubMed ID: 1651328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dependence of kidney morphogenesis on the expression of nerve growth factor receptor.
    Sariola H; Saarma M; Sainio K; Arumäe U; Palgi J; Vaahtokari A; Thesleff I; Karavanov A
    Science; 1991 Oct; 254(5031):571-3. PubMed ID: 1658930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoclonal antibody against human glioblastoma multiforme (U-87MG) immunoprecipitates a protein of molecular mass 38 kDa and inhibits tumor growth in nude mice.
    Dastidar SG; Sharma SK
    J Neuroimmunol; 1995 Jan; 56(1):91-8. PubMed ID: 7822486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generation of the truncated form of the nerve growth factor receptor by rat Schwann cells. Evidence for post-translational processing.
    Barker PA; Miller FD; Large TH; Murphy RA
    J Biol Chem; 1991 Oct; 266(28):19113-9. PubMed ID: 1655773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurement of human nerve growth factor binding sites in brain and in peripheral tissues by a specific immunoprecipitation assay.
    Ehrhard P; Gudat F; Otten U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):251-7. PubMed ID: 2177851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Schwann cell antigen recognized by monoclonal antibody 217c is the rat low-affinity nerve growth factor receptor.
    Stemple DL; Anderson DJ
    Neurosci Lett; 1991 Mar; 124(1):57-60. PubMed ID: 1649981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification, purification, and characterization of truncated forms of the human nerve growth factor receptor.
    Zupan AA; Osborne PA; Smith CE; Siegel NR; Leimgruber RM; Johnson EM
    J Biol Chem; 1989 Jul; 264(20):11714-20. PubMed ID: 2545681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nerve growth factor receptor immunoreactivity on the tunica adventitia of intramuscular blood vessels in childhood muscular dystrophies.
    Zhao J; Yoshioka K; Miike T; Kageshita T; Arao T
    Neuromuscul Disord; 1991; 1(2):135-41. PubMed ID: 1668370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nerve growth factor and its receptor in schizophrenia.
    Zakharyan R; Atshemyan S; Gevorgyan A; Boyajyan A
    BBA Clin; 2014 Jun; 1():24-9. PubMed ID: 26675984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid preparation of lysate for immunoprecipitation using a low protein-binding micro-filter.
    Ayres M; Marshall HB; Ishikawa J; Takahashi R
    Biotechniques; 1991 May; 10(5):578-80. PubMed ID: 1910772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microtubule proteins in the nerve growth factor mediated response. Interaction between the nerve growth factor and its target cells.
    Levi-Montalcini R; Revoltella R; Calissano P
    Recent Prog Horm Res; 1974; 30(0):635-69. PubMed ID: 4367111
    [No Abstract]   [Full Text] [Related]  

  • 53. Ultrastructural study on a variety of non-neural cells immunoreactive for nerve growth factor receptor in developing rats.
    Amano O; Abe H; Kondo H
    Acta Anat (Basel); 1991; 141(3):212-9. PubMed ID: 1661555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Isolation of neuropeptide receptors; morphological methods].
    Itoga E; Kito S
    Nihon Rinsho; 1983 May; 41(5):1062-7. PubMed ID: 6313988
    [No Abstract]   [Full Text] [Related]  

  • 55. Muscling toward therapy with ERBB3 and NGFR.
    Ho ATV; Blau HM
    Nat Cell Biol; 2018 Jan; 20(1):6-7. PubMed ID: 29269948
    [No Abstract]   [Full Text] [Related]  

  • 56. Listening to the Whispers in Neuroimmune Crosstalk: A Comprehensive Workflow to Investigate Neurotrophin Receptor p75NTR Under Endogenous, Low Abundance Conditions.
    Dorschner BW; Wiedemuth R; Funke AC; Gentzel M; Rogers ML; Brenner S; Thieme S
    Front Immunol; 2021; 12():648283. PubMed ID: 33936068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reverse-phase high-performance liquid chromatography of nerve growth factor receptor-like proteins identified with monoclonal antibodies.
    Shan DE; Beck CE; Werrbach-Perez K; Perez-Polo JR
    J Neurosci Res; 1990 Dec; 27(4):620-32. PubMed ID: 1964179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of binding properties and structure of NGF receptor on PC12 pheochromocytoma and A875 melanoma cells.
    Buxser SE; Watson L; Johnson GL
    J Cell Biochem; 1983; 22(4):219-33. PubMed ID: 6323498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of nerve growth factor receptor expression in human neuroblastoma and neuroepithelioma cell lines.
    Baker DL; Reddy UR; Pleasure D; Thorpe CL; Evans AE; Cohen PS; Ross AH
    Cancer Res; 1989 Aug; 49(15):4142-6. PubMed ID: 2545334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple defects of the nerve growth factor receptor in human neuroblastomas.
    Azar CG; Scavarda NJ; Reynolds CP; Brodeur GM
    Cell Growth Differ; 1990 Sep; 1(9):421-8. PubMed ID: 1963076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.